MAPT and Alzheimer disease: According to the most recent classification of FTLD, FTLD-tau includes non-AD tauopathies such as Pick’s disease (PiD), PSP, corticobasal degeneration (CBD), argyrophilic grain disease (AGD), globular glial tauopathy (GGT) as well as FTLD-tau linked to mutations in MAPT (Mackenzie and Neumann, 2016; Figure 2B).